Infraredx, a Nipro Company Announces FDA Approval of MakotoTM Intravascular Imaging System to Expand Efficiency Marking

25 April 2019

Infraredx, a Nipro Company is a pioneer in the field of intravascular imaging for coronary artery disease, the company announced today that the US Food and Drug Administration (FDA) 510(k) approval